Vanda Pharmaceuticals Inc (VNDA)
4.935
+0.04
(+0.71%)
USD |
NASDAQ |
Nov 21, 16:00
4.935
0.00 (0.00%)
After-Hours: 19:38
Vanda Pharmaceuticals Market Cap: 287.75M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 285.71M |
| November 19, 2024 | 286.88M |
| November 18, 2024 | 290.37M |
| November 15, 2024 | 291.54M |
| November 14, 2024 | 297.37M |
| November 13, 2024 | 318.36M |
| November 12, 2024 | 314.86M |
| November 11, 2024 | 311.37M |
| November 08, 2024 | 302.62M |
| November 07, 2024 | 292.71M |
| November 06, 2024 | 285.13M |
| November 05, 2024 | 279.30M |
| November 04, 2024 | 282.79M |
| November 01, 2024 | 271.72M |
| October 31, 2024 | 271.13M |
| October 30, 2024 | 265.88M |
| October 29, 2024 | 273.46M |
| October 28, 2024 | 278.70M |
| October 25, 2024 | 265.29M |
| October 24, 2024 | 263.54M |
| October 23, 2024 | 273.46M |
| October 22, 2024 | 275.79M |
| October 21, 2024 | 275.79M |
| October 18, 2024 | 286.28M |
| October 17, 2024 | 276.08M |
| Date | Value |
|---|---|
| October 16, 2024 | 285.70M |
| October 15, 2024 | 279.87M |
| October 14, 2024 | 280.45M |
| October 11, 2024 | 258.88M |
| October 10, 2024 | 257.13M |
| October 09, 2024 | 260.63M |
| October 08, 2024 | 261.79M |
| October 07, 2024 | 262.38M |
| October 04, 2024 | 269.96M |
| October 03, 2024 | 262.38M |
| October 02, 2024 | 267.62M |
| October 01, 2024 | 264.71M |
| September 30, 2024 | 273.46M |
| September 27, 2024 | 272.21M |
| September 26, 2024 | 276.29M |
| September 25, 2024 | 282.71M |
| September 24, 2024 | 289.12M |
| September 23, 2024 | 276.88M |
| September 20, 2024 | 268.72M |
| September 19, 2024 | 271.05M |
| September 18, 2024 | 288.53M |
| September 17, 2024 | 287.95M |
| September 16, 2024 | 296.11M |
| September 13, 2024 | 297.28M |
| September 12, 2024 | 290.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
194.46M
Minimum
Nov 09 2023
1.197B
Maximum
Jun 30 2021
576.31M
Average
582.03M
Median
Market Cap Benchmarks
| Zevra Therapeutics Inc | 488.12M |
| Black Diamond Therapeutics Inc | 137.78M |
| Edgewise Therapeutics Inc | 3.031B |
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
Market Cap Related Metrics
| PS Ratio | 1.499 |
| Price to Book Value | 0.5317 |
| Price | 4.935 |
| Earnings Yield | -5.67% |